继续医学教育Issue(8)：130-131,2.DOI:10.3969/j.issn.1004-6763.2015.08.078
2型糖尿病治疗新药剂利拉利汀的临床疗效观察
Analysis of the Clinical Application in the Treatment of Type 2 Diabetes of New Agentia Linagliptin
张天英 1李洪影1
作者信息
- 1. 佳木斯大学附属第一医院药剂科，黑龙江 佳木斯 154002
- 折叠
摘要
Abstract
Objective To investigate the effect of new agentia linagliptin application in type 2 diabetes mellitus patients.MethodsA total of 60 type 2 diabetic patients in our hospital were divided into control group and observation group, 30 cases in each group of patients, a total efifciency were compared between the two groups of treatment.Results After treatment, the patients in the control group the total effective rate of treatment was 70%, the patients in the observation group were treated with a total effective rate of 96.67%, patients in the observation group treatment effect is better than that of control group.Conclusion The new agentia linagliptin application has good results in the treatment of type 2 diabetes.关键词
新药剂/利拉利汀/2型糖尿病Key words
New agentia/Linagliptin/Type 2 diabetes分类
医药卫生引用本文复制引用
张天英,李洪影..2型糖尿病治疗新药剂利拉利汀的临床疗效观察[J].继续医学教育,2015,(8):130-131,2.
